Documentation Centre

 

 

  of 6541 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Closing the remaining evidence gap: Randomized controlled trial data to support statin therapy for low-density lipoprotein ≥190 mg/dL. Circulation. 2017;136:1892-1894 February 21, 2018 Closing the remaining evidence gap: Randomized controlled trial data to support statin therapy for low-density lipoprotein ≥190 mg/dL. Circulation. 2017;136:1892-1894 Watson KE, Fonarow GC Key Publications
Cardiovascular health, simplified. J Am Coll Cardiol. 2017;70:2474-2475 February 21, 2018 Cardiovascular health, simplified. J Am Coll Cardiol. 2017;70:2474-2475 Blumenthal RS, Ambinder DI, McEvoy JW Key Publications
Inflammation and atherosclerosis: The end of a controversy. Circulation. 2017;136:1875-1877 February 20, 2018 Inflammation and atherosclerosis: The end of a controversy. Circulation. 2017;136:1875-1877 Hansson GK Key Publications
Biochemical risk markers and 10-year incidence of atherosclerotic cardiovascular disease: independent predictors, improvement in pooled cohort equation, and risk reclassification. Am Heart J. 2017;193:95-103 February 20, 2018 Biochemical risk markers and 10-year incidence of atherosclerotic cardiovascular disease: independent predictors, improvement in pooled cohort equation, and risk reclassification. Am Heart J. 2017;193:95-103 Akintoye E, Briasoulis A, Afonso L Key Publications
Low-density lipoprotein cholesterol lowering for the primary prevention of cardiovascular disease among men with primary elevations of low-density lipoprotein cholesterol levels of 190 mg/dL or above: Analyses from the WOSCOPS (West of Scotland Coronary Prevention Study) 5-year randomized trial and 20-year observational follow-up. Circulation. 2017;136:1878-1891 February 20, 2018 Low-density lipoprotein cholesterol lowering for the primary prevention of cardiovascular disease among men with primary elevations of low-density lipoprotein cholesterol levels of 190 mg/dL or above: Analyses from the WOSCOPS (West of Scotland Coronary Prevention Study) 5-year randomized trial and 20-year observational follow-up. Circulation. 2017;136:1878-1891 Vallejo-Vaz AJ, Robertson M, Catapano AL, Watts GF, Kastelein JJ, Packard CJ, Ford I, Ray KK Key Publications
Predicting subclinical atherosclerosis in low-risk individuals: Ideal cardiovascular health score and Fuster-BEWAT score. J Am Coll Cardiol. 2017;70:2463-2473 February 20, 2018 Predicting subclinical atherosclerosis in low-risk individuals: Ideal cardiovascular health score and Fuster-BEWAT score. J Am Coll Cardiol. 2017;70:2463-2473 Fernández-Alvira JM, Fuster V, Pocock S, Sanz J, Fernández-Friera L, Laclaustra M, Fernández-Jiménez R, Mendiguren J, Fernández-Ortiz A, Ibáñez B, Bueno H Key Publications
Do we need a patient-centered target for systolic blood pressure in hypertensive patients with type 2 diabetes mellitus? Hypertension. 2017;70:1273-1282 February 19, 2018 Do we need a patient-centered target for systolic blood pressure in hypertensive patients with type 2 diabetes mellitus? Hypertension. 2017;70:1273-1282 Wan EYF, Yu EYT, Fung CSC, Chin WY, Fong DYT, Chan AKC, Lam CLK Key Publications
Enjoyment of spicy flavor enhances central salty-taste perception and reduces salt intake and blood pressure. Hypertension. 2017;70:1291-1299 February 19, 2018 Enjoyment of spicy flavor enhances central salty-taste perception and reduces salt intake and blood pressure. Hypertension. 2017;70:1291-1299 Li Q, Cui Y, Jin R, Lang H, Yu H, Sun F, He C, Ma T, Li Y, Zhou X, Liu D, Jia H, Chen X, Zhu Z Key Publications
Obesity: The myth of innocent obesity. Nat Rev Endocrinol. 2017;13:691-692 February 19, 2018 Obesity: The myth of innocent obesity. Nat Rev Endocrinol. 2017;13:691-692 Blüher M Key Publications
Glucose effectiveness, but not insulin sensitivity, is improved after short-term interval training in individuals with type 2 diabetes mellitus: a controlled, randomised, crossover trial. Diabetologia. 2017;60:2432-2442 February 16, 2018 Glucose effectiveness, but not insulin sensitivity, is improved after short-term interval training in individuals with type 2 diabetes mellitus: a controlled, randomised, crossover trial. Diabetologia. 2017;60:2432-2442 Karstoft K, Clark MA, Jakobsen I, Knudsen SH, van Hall G, Pedersen BK, Solomon TPJ Key Publications

  of 6541 Next page

Go to page: of